demonstrated that paclitaxel-induced tumor cell debris can induce expression of HO-1 in macrophages, resulting in an anti-tumor immune response and dampened efficacy of paclitaxel in breast cancer (20). This evidence concerns the gene HMOX1 and neoplasm.